Replimune (REPL) Other Accumulated Expenses (2018 - 2021)
Replimune's (REPL) quarterly Other Accumulated Expenses came in at $514000.0 in Q1 2021, up 69.64% year-on-year from $303000.0 in Q1 2020, and down 0.96% quarter-over-quarter from $519000.0 in Q4 2020.
Replimune (REPL) Other Accumulated Expenses (2018 - 2021) Analysis & Trends
Replimune has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $514000.0 for Q1 2021.
- Other Accumulated Expenses for Q1 2021 came in at $514000.0, up 69.64% year-over-year; the trailing twelve-month figure through Mar 2021 was $514000.0 (up 69.64% YoY), and the FY2021 annual result was $514000.0, up 69.64% from the prior year.
- Other Accumulated Expenses came in at $514000.0 for Q1 2021 at Replimune, down from $519000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $974000.0 in Q3 2020 to a low of $129000.0 in Q2 2018.
- The 4-year median for Other Accumulated Expenses is $303000.0 (2020), against an average of $379538.5.
- Across the five-year window, Other Accumulated Expenses advanced 2.33% in 2019 and soared 335.61% in 2020, its largest moves.
- Replimune's Other Accumulated Expenses stood at $251000.0 in 2018, then soared by 37.45% to $345000.0 in 2019, then jumped by 50.43% to $519000.0 in 2020, then decreased by 0.96% to $514000.0 in 2021.
- The last three Other Accumulated Expenses figures came in at $514000.0 (Q1 2021), $519000.0 (Q4 2020), and $974000.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 514,000.00 |
| Dec 31, 2020 | 519,000.00 |
| Sep 30, 2020 | 974,000.00 |
| Jun 30, 2020 | 575,000.00 |
| Mar 31, 2020 | 303,000.00 |
| Dec 31, 2019 | 345,000.00 |
| Sep 30, 2019 | 608,000.00 |
| Jun 30, 2019 | 132,000.00 |
| Mar 31, 2019 | 273,000.00 |
| Dec 31, 2018 | 251,000.00 |
| Sep 30, 2018 | 158,000.00 |
| Jun 30, 2018 | 129,000.00 |
| Mar 31, 2018 | 153,000.00 |